Hepion Pharmaceuticals, Inc.·4

Feb 21, 8:01 PM ET

JACOB GARY S 4

4 · Hepion Pharmaceuticals, Inc. · Filed Feb 21, 2024

Insider Transaction Report

Form 4
Period: 2024-02-19
JACOB GARY S
DirectorCEO and President
Transactions
  • Award

    Stock Options

    2024-02-19+85,000102,120 total
    Exercise: $2.56From: 2024-02-19Exp: 2026-02-19Common Stock (85,000 underlying)

Documents

1 file
  • 4
    ownership.xmlPrimary